EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) stock closed at $9.05 on 8/21/24 after a major increase of 17.2%. NORMAL trading volume accompanied the advance. The stock has risen 15.3% during the last week but has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
EYPT is expected to continue to be a modest Value Eraser reflecting capital returns that are forecasted to fall short of the cost of capital.
EyePoint Pharmaceuticals has a current Value Trend Rating of F (Lowest Rating). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. EyePoint Pharmaceuticals has a neutral Appreciation Score of 52 but a very low Power Rating of 1, leading to the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment